Key Facts About Medicare Part D Enrollment and Costs in 2023
(By Juliette Cubanski and Anthony Damico for Kaiser Family Foundation Published: Jul 26, 2023) The Medicare Part D program provides
Read More
Part D/Prescription Drugs
New Weight Loss Drugs Carry High Price Tags and Lots of Questions for Seniors
(By Judith Graham for KFF Health News) Corlee Morris has dieted throughout her adult life. After her weight began climbing
Read MoreAn experimental Alzheimer’s drug outperforms one just approved by the FDA
(By Jon Hamilton for NPR) Patients in the early stages of Alzheimer’s may soon have a new option to stave
Read MoreWill the new Alzheimer’s drug put pressure on Medicare premiums?
The FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read More10 Prescription Drugs Accounted for $48 Billion in Medicare Part D Spending in 2021, or More Than One-Fifth of Part D Spending That Year
(By Chris Lee for The Kaiser Family Foundation published July 12, 2023) A new KFF analysis finds that the 10
Read MoreWait, What’s a PBM?
(By Dan Weissmann for KFF Health News) You might wonder, wait, what’s a PBM exactly? And also, why am I
Read MoreHHS Announces Actions to Protect Consumers and Lower Health Care Costs
(Source – www.cms.gov/newsroom) The U.S. Department of Health and Human Services (HHS), announced actions to protect consumers from junk health
Read MoreLeqembi could cost Medicare up to $17.8B
(By Rylee Wilson for Becker’s Hospital Review) Leqembi, the newly-approved drug that can slow the progression of Alzhemier’s disease, will
Read MoreStatement: Broader Medicare Coverage of Leqembi Available Following FDA Traditional Approval
(Source – www.cms.gov/newsroom) Broader Medicare coverage is now available for Biogen and Eisai’s Leqembi (the brand name for lecanemab) following
Read MoreWhat to know about the drug price fight in those TV ads
(By Arthur Allen for NPR) In recent months ominous ads about prescription drugs have flooded the TV airwaves. Perhaps by
Read More